Investigational Drug Information for Amcenestrant
✉ Email this page to a colleague
What is the drug development status for Amcenestrant?
Amcenestrant is an investigational drug.
There have been 10 clinical trials for Amcenestrant.
The most recent clinical trial was a Phase 1 trial, which was initiated on October 14th 2020.
The most common disease conditions in clinical trials are Breast Neoplasms, Triple Negative Breast Neoplasms, and Hemangiosarcoma. The leading clinical trial sponsors are Sanofi, Stanford University, and Alliance for Clinical Trials in Oncology.
Summary for Amcenestrant
| US Patents | 0 |
| International Patents | 32 |
| US Patent Applications | 23 |
| WIPO Patent Applications | 14 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 1 (2020-10-14) |
| Vendors | 30 |
Recent Clinical Trials for Amcenestrant
| Title | Sponsor | Phase |
|---|---|---|
| Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Normal Hepatic Function | Sanofi | Phase 1 |
| Umbrella Trial Testing Integrative Subtype-Targeted Therapeutics in HR+ /HER2-Negative Breast Cancer | United States Department of Defense | Phase 2 |
| Umbrella Trial Testing Integrative Subtype-Targeted Therapeutics in HR+ /HER2-Negative Breast Cancer | Stanford University | Phase 2 |
Clinical Trial Summary for Amcenestrant
Top disease conditions for Amcenestrant
Top clinical trial sponsors for Amcenestrant
US Patents for Amcenestrant
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Amcenestrant
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Amcenestrant | Argentina | AR107616 | 2036-02-15 | ⤷ Sign Up |
| Amcenestrant | Australia | AU2017221083 | 2036-02-15 | ⤷ Sign Up |
| Amcenestrant | Brazil | BR112018016490 | 2036-02-15 | ⤷ Sign Up |
| Amcenestrant | Canada | CA3014424 | 2036-02-15 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
